Terms: = Ovarian cancer AND HOXA11, HOX1, 3207, ENSG00000005073, HOX1I, P31270
13 results:
1. Long non-coding RNA hoxa11-AS knockout inhibits proliferation and overcomes drug resistance in ovarian cancer.
Chen Y; Cui Z; Wu Q; Wang H; Xia H; Sun Y
Bioengineered; 2022 May; 13(5):13893-13905. PubMed ID: 35706412
[TBL] [Abstract] [Full Text] [Related]
2. Combined expression of hoxa11 and CD10 identifies endometriosis versus normal tissue and tumors.
Bergman-Larsson J; Gustafsson S; Méar L; Huvila J; Tolf A; Olovsson M; Pontén F; Edqvist PD
Ann Diagn Pathol; 2022 Feb; 56():151870. PubMed ID: 34844098
[TBL] [Abstract] [Full Text] [Related]
3. The role of the long non-coding RNA hoxa11-AS in promoting proliferation and metastasis of malignant tumors.
Lu S; Jiang X; Su Z; Cui Z; Fu W; Tai S
Cell Biol Int; 2018 Dec; 42(12):1596-1601. PubMed ID: 30095197
[TBL] [Abstract] [Full Text] [Related]
4. hoxa11 antisense long noncoding RNA (hoxa11-AS): A promising lncRNA in human cancers.
Lu CW; Zhou DD; Xie T; Hao JL; Pant OP; Lu CB; Liu XF
Cancer Med; 2018 Aug; 7(8):3792-3799. PubMed ID: 29992790
[TBL] [Abstract] [Full Text] [Related]
5. Long Non-coding RNA
Yim GW; Kim HJ; Kim LK; Kim SW; Kim S; Nam EJ; Kim YT
Cancer Res Treat; 2017 Jul; 49(3):656-668. PubMed ID: 27737536
[TBL] [Abstract] [Full Text] [Related]
6. A functional variant in hoxa11-AS, a novel long non-coding RNA, inhibits the oncogenic phenotype of epithelial ovarian cancer.
Richards EJ; Permuth-Wey J; Li Y; Chen YA; Coppola D; Reid BM; Lin HY; Teer JK; Berchuck A; Birrer MJ; Lawrenson K; Monteiro AN; Schildkraut JM; Goode EL; Gayther SA; Sellers TA; Cheng JQ
Oncotarget; 2015 Oct; 6(33):34745-57. PubMed ID: 26430965
[TBL] [Abstract] [Full Text] [Related]
7. The novel, small-molecule DNA methylation inhibitor SGI-110 as an ovarian cancer chemosensitizer.
Fang F; Munck J; Tang J; Taverna P; Wang Y; Miller DF; Pilrose J; Choy G; Azab M; Pawelczak KS; VanderVere-Carozza P; Wagner M; Lyons J; Matei D; Turchi JJ; Nephew KP
Clin Cancer Res; 2014 Dec; 20(24):6504-16. PubMed ID: 25316809
[TBL] [Abstract] [Full Text] [Related]
8. Epigenetic resensitization to platinum in ovarian cancer.
Matei D; Fang F; Shen C; Schilder J; Arnold A; Zeng Y; Berry WA; Huang T; Nephew KP
Cancer Res; 2012 May; 72(9):2197-205. PubMed ID: 22549947
[TBL] [Abstract] [Full Text] [Related]
9. A phase 1 and pharmacodynamic study of decitabine in combination with carboplatin in patients with recurrent, platinum-resistant, epithelial ovarian cancer.
Fang F; Balch C; Schilder J; Breen T; Zhang S; Shen C; Li L; Kulesavage C; Snyder AJ; Nephew KP; Matei DE
Cancer; 2010 Sep; 116(17):4043-53. PubMed ID: 20564122
[TBL] [Abstract] [Full Text] [Related]
10. HOXA methylation in normal endometrium from premenopausal women is associated with the presence of ovarian cancer: a proof of principle study.
Widschwendter M; Apostolidou S; Jones AA; Fourkala EO; Arora R; Pearce CL; Frasco MA; Ayhan A; Zikan M; Cibula D; Iyibozkurt CA; Yavuz E; Hauser-Kronberger C; Dubeau L; Menon U; Jacobs IJ
Int J Cancer; 2009 Nov; 125(9):2214-8. PubMed ID: 19621443
[TBL] [Abstract] [Full Text] [Related]
11. hoxa11 DNA methylation--a novel prognostic biomarker in ovarian cancer.
Fiegl H; Windbichler G; Mueller-Holzner E; Goebel G; Lechner M; Jacobs IJ; Widschwendter M
Int J Cancer; 2008 Aug; 123(3):725-9. PubMed ID: 18478570
[TBL] [Abstract] [Full Text] [Related]
12. [Morphogenesis and differentiation of the female genital tract. Genetic determinism and epithelium-stromal interactions].
Amălinei C
Rev Med Chir Soc Med Nat Iasi; 2007; 111(1):200-9. PubMed ID: 17595868
[TBL] [Abstract] [Full Text] [Related]
13. Lineage infidelity of epithelial ovarian cancers is controlled by HOX genes that specify regional identity in the reproductive tract.
Cheng W; Liu J; Yoshida H; Rosen D; Naora H
Nat Med; 2005 May; 11(5):531-7. PubMed ID: 15821746
[TBL] [Abstract] [Full Text] [Related]
